Work

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/leu.2017.120

Authors: A Dispenzieri, C Tong, B LaPlant, M Q Lacy, K Laumann, D Dingli, Y Zhou, M J Federspiel, M A Gertz, S Hayman, F Buadi, M O'Connor, V J Lowe, K-W Peng, S J Russell

Institution: Mayo Clinic

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Virotherapy for Relapsed Refractory Multiple Myeloma, Mayo Clinic Center for Clinical and Translational Science (CCaTS), Measles Virotherapy for Multiple Myeloma, Mayo Clinic Multiple Myeloma SPORE

OpenAlex ID: W2609151904

FWCI: 12.67

Cites: 21

Cited by: 155

Related to: 10